About
Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
Team & affiliation
Founders: Ulrich Gartner, Jayson Dallas.
Timeline
- 2019Founded
- 2020Pre-seed / friends & family
- 2021Seed round
- 2022Series A
- 2023Series B
Region context
Rivus Pharmaceuticals is one of 9 Biotech companies we track in Central Virginia, based in Charlottesville — about 11% of the region's 82 startups. 5 of the region's companies are at the Series B stage.
Central Virginia centers on UVA-adjacent biotech, climate, and software companies, with Lynchburg manufacturing nearby.
See the full Central Virginia ecosystem →